We are pleased to announce that Laura Jacobus has been selected as the recipient of the 2025 GME Program Administrator Excellence Award by the Graduate Office of Medical Education at Michigan Medicine. Awardees are nominated by colleagues and selected by a committee of their peers. This is a highly competitive award that recognizes the service, spirit, and initiative of the nominee.
The University of Michigan’s Department of Pathology is celebrating Match Day 2025, a pivotal moment when aspiring pathologists discover where they will continue their residency training. Those joining U-M Pathology will benefit from cutting-edge research, state-of-the-art laboratories, and a collaborative learning environment as they embark on their journey to shape the future of diagnostic medicine.
On Thursday, March 20th, the National Institutes of Health, National Cancer Institute presented its Rising Scholars Lecture with pathology’s Dr. Abhijit Parolia, assistant professor of experimental pathology, entitled NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis. Rising Scholar lectures showcase NCI-supported early career researchers with outstanding research findings.
Congratulations to Molecular and Cellular Pathology graduate student Shih-Chun Alec Chu for successfully defending his thesis, “Multimodal and Multiomic Integration in Precision Oncology” earning the coveted PhD degree.
One of the key qualities of expert pathologists is that they learn to expect the unexpected. In the Michigan Medicine Department of Pathology, our pathologists and collaborators recently reported on some of these unexpected findings.
Mixed epithelial and stromal tumors (MESTs) are rare, usually benign tumors that are typically found in the kidney in perimenopausal women. These tumors can clinically mimic malignant tumors, so accurately identifying them is essential. Most of the time, these tumors are found incidentally, but some patients will present with abdominal or flank pain.
Michigan Medicine First in State to Join the Alloantibody Exchange